From: Changes in the proteomic profiles of mouse brain after infection with cyst-forming Toxoplasma gondii
Spot No. | Accession No. | Protein name | Score | Expect | Queries matched | Sequence Coverage | Nominal mass | Calculated pI value | Matched peptides | Fold change (Infected/non-infected)A | Functional categoriesB |
---|---|---|---|---|---|---|---|---|---|---|---|
Day 7, down-regulated proteins | |||||||||||
1 | IPI00230394 | Lamin-B1 | 288 | 9.00E-25 | 27 | 36 | 66973 | 5.11 | ASAPATPLSPTR;LQEKEELR;SLETENSALQLQVTEREEVR;ALYETELADARR;LREYEAALNSK;VDLENRCQSLTEDLEFRKNMYEEEINETRR;LVEVDSGR;LAQALHEMREQHDAQVRLYKEELEQTYHAK;LALDMEISAYR;LKNTSEQDQPMGGWEMIR;NQNSWGTGEDVK;NSQGEEVAQR;TTIPEEEEEEEEEPIGVAVEEERFHQQGAPR | −2.91 | Structural molecule activity |
2 | IPI00944143 | Serpin B6 isoform a | 218 | 9.00E-18 | 9 | 25 | 45201 | 5.99 | SRPGCCAGPRGYR;NVFLSPMSISSALAMVFMGAK;TGTQYLLR;FYEAELEELDFQGATEESR;FIEWTR;LGMTDAFGGR;AFVEVNEEGTEAAAATAGMMTVR | −1.68 | Enzyme regulator activity and metabolic process |
3 | IPI00110721 | Isoform 1 of Glyoxalase domain-containing protein 4 | 508 | 9.00E-47 | 12 | 41 | 33581 | 5.28 | FQTVHFFRDVLGMQVLRHEEFEEGCK;LGNDFMGITLASSQAVSNAR;VAEGIFETEAPGGYKFYLQDR;IYEQDEEKQR;LELQGIQGAVDHAAAFGR;ELPDLEDLMKR;LLDDAMEADKSDEWFATR | −1.51 | Cell part and organelle |
4 | IPI00113660 | Proteasome activator complex subunit 3 | 471 | 4.50E-43 | 9 | 42 | 29602 | 5.69 | ITSEAEDLVANFFPK;RLDECEEAFQGTK;SNQQLVDIIEKVKPEIR;IEDGNNFGVSIQEETVAELRTVESEAASYLDQISRYYITR;YPHVEDYRRTVTEIDEKEYISLR | −1.70 | Enzyme regulator activity |
5 | IPI00130344 | Chloride intracellular channel protein 1 | 202 | 3.60E-16 | 6 | 39 | 27338 | 5.09 | IGNCPFSQR;YPKLAALNPESNTSGLDIFAK;VLDNYLTSPLPEEVDETSAEDEGISQR;GFTIPEAFR;YLSNAYAREEFASTCPDDEEIELAYEQVAR | −1.89 | Transporter activity |
6 | IPI00121851 | Prefoldin subunit 3 | 133 | 2.90E-09 | 4 | 15 | 22592 | 6 | FLLADNLYCK;NLDSLEEDLDFLR;VYNWDVKR | −1.51 | Metabolic process |
7 | IPI00315794 | Cytochrome b5 | 212 | 3.60E-17 | 6 | 54 | 16365 | 4.79 | VEGSEPSVTYYR;NSAEETWMVIHGRVYDITRFLSEHPGGEEVLLEQAGADATESFEDVGHSPDAR;QYYIGDVHPSDLKPK | −1.70 | Binding and enzyme activator activity |
8 | IPI00124501 | Galectin-related protein A | 257 | 1.10E-21 | 8 | 57 | 19172 | 5.12 | LDDGHLNNSLGSPVQADVYFPRLIVPFCGHIK;AVFTDR;NSCISGERGEEQSAIPYFPFIPDQPFRVEILCEHPR;VFVDGHQLFDFYHRIQTLSAIDTIK | −1.74 | Binding |
9 | IPI00308984 | Eukaryotic translation initiation factor 1A | 248 | 9.00E-21 | 3 | 28 | 16564 | 5.07 | ELVFKEDGQEYAQVIK;LEAMCFDGVKR;VWINTSDIILVGLR | −1.67 | Binding |
Day 7, up-regulated proteins | |||||||||||
10 | IPI00131830 | Serine protease inhibitor A3K | 470 | 5.70E-43 | 9 | 28 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR | 2.55 | Enzyme regulator activity |
11 | IPI00131830 | Serine protease inhibitor A3K | 511 | 4.50E-47 | 12 | 35 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETK;AVLDVAETGTEAAAATGVIGGIR | 3.15 | Enzyme regulator activity |
12 | IPI00131830 | Serine protease inhibitor A3K | 463 | 2.90E-42 | 10 | 28 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR | 6.30 | Enzyme regulator activity |
13 | IPI00131830 | Serine protease inhibitor A3K | 564 | 2.30E-52 | 14 | 35 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETKK;AVLDVAETGTEAAAATGVIGGIR | 4.02 | Enzyme regulator activity |
14 | IPI00131830 | Serine protease inhibitor A3K | 596 | 1.40E-55 | 12 | 35 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETK;AVLDVAETGTEAAAATGVIGGIR | 5.80 | Enzyme regulator activity |
15 | IPI00310972 | GTP-GDP dissociation stimulator 1 isoform b | 490 | 5.70E-45 | 18 | 27 | 61381 | 5.28 | NEFMR;DQEVLLQTGR;EQFASTNIAEELVK;QIEHDKREMIFEVLAPLAENDAIK;LMDLLDRHVEDGNVTVQHAALSALR;SEMPPVQFK;MLIDAQAEAAEQLGK;LVEWCEAKDHAGVMGESNR;DLASAQLVQILHRLLADER;SVAQQASLTEQR | 8.32 | Cell part and organelle part |
Day 14, down-regulated proteins | |||||||||||
16 | IPI00131871 | COP9 signalosome complex subunit 4 | 449 | 7.20E-41 | 18 | 50 | 46541 | 5.57 | QLLTDFCTHLPNLPDSTAK;VISFEEQVASIRQHLASIYEKEEDWRNAAQVLVGIPLETGQKQYNVDYKLETYLK;LYLEDDDPVQAEAYINRASLLQNESTNEQLQIHYK;KFIEAAQR;TIVHESERLEALKHALHCTILASAGQQR;MLATLFKDERCQQLAAYGILEK;ATTADGSSILDR;IASQMITEGRMNGFIDQIDGIVHFETR | −2.50 | Metabolic process |
17 | IPI00338039 | Tubulin beta-2A chain | 591 | 4.50E-55 | 22 | 42 | 50274 | 4.78 | MREIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGSYHGDSDLQLERINVYYNEAAGNK;AILVDLEPGTMDSVR;GHYTEGAELVDSVLDVVRK;IREEYPDRIMNTFSVMPSPK;FPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVPELTQQMFDSKNMMAACDPR;ISEQFTAMFRR | −1.90 | Structural molecule activity |
18 | IPI00113660 | Proteasome activator complex subunit 3 | 450 | 5.70E-41 | 11 | 43 | 29602 | 5.69 | ERITSEAEDLVANFFPK;RLDECEEAFQGTK;SNQQLVDIIEKVKPEIR;IEDGNNFGVSIQEETVAELRTVESEAASYLDQISRYYITR;YPHVEDYRRTVTEIDEKEYISLR | −2.04 | Enzyme regulator activity |
19 | IPI00407019 | Tetratricopeptide repeat protein 19 | 348 | 9.00E-31 | 12 | 23 | 41550 | 5.87 | LSIMKDEPEAAELILHDALRLAYESDNRK;GQLENAEQLFK;QLSQAQR;ALQICQEIQGER;EIYQEALKR;RDEVSVQHIREELAELSR | −1.99 | Cell part, organelle and organelle part |
20 | IPI00133440 | Prohibitin | 688 | 9.00E-65 | 14 | 42 | 29859 | 5.57 | AVIFDRFR;DLQNVNITLRILFRPVASQLPRIYTSIGEDYDERVLPSITTEILK;FDAGELITQR;QVSDDLTER;QVAQQEAER;AAELIANSLATAGDGLIELRKLEAAEDIAYQLSR | −4.73 | Metabolic process |
21 | IPI00313962 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | 340 | 5.70E-30 | 8 | 39 | 25165 | 5.14 | LGVAGQWR;QIEELKGQEVSPK;QFLSETEKLSPEDR;CFEKNEAIQAAHDSVAQEGQCR;MPFPVNHGASSEDSLLQDAAK;EFTEREQGEVR | −1.68 | Cell proliferation |
22 | IPI00322312 | Rho GDP-dissociation inhibitor 1 | 536 | 1.40E-49 | 12 | 49 | 23450 | 5.12 | SIQEIQELDKDDESLR;YKEALLGRVAVSADPNVPNVIVTR;EGVEYR;YIQHTYR;IDKTDYMVGSYGPRAEEYEFLTPMEEAPK;FTDDDKTDHLSWEWNLTIK | −4.10 | Enzyme regulator activity |
23 | IPI00845712 | Isoform 1 of UPF0424 protein C1orf128 homolog | 540 | 5.70E-50 | 17 | 73 | 24405 | 5.48 | CAAEREEPPEQRGLAYGLYLR;LQCLNESR;GVFKPWEER;FVESDADEELLFNIPFTGNVKLKGVIIMGEDDDSHPSEMR;NIPQMSFDDTEREPEQTFSLNRDITGELEYATK;IFYIGLRGEWTELRRHEVTICNYEASANPADHRVHQVTPQTHFIS; | −2.40 | Cell part, organelle and organelle part |
24 | IPI00221826 | Isoform Short of Splicing factor, arginine/serine-rich 3 | 226 | 1.40E-18 | 7 | 41 | 14422 | 10.12 | DSCPLDCK;AFGYYGPLRSVWVARNPPGFAFVEFEDPR;NRGPPPSWGR;DDYRR | −1000000 | Metabolic process |
Day 14, up-regulated proteins | |||||||||||
25 | IPI00123613 | Protein kinase C and casein kinase substrate in neurons protein 1 | 382 | 3.60E-34 | 15 | 40 | 50886 | 5.15 | LCNDLMSCVQER;AYAQQLTDWAKR;AWGAMMTEADKVSELHQEVK;AYHLACKEER;TTPQYMEGMEQVFEQCQQFEEKR;HLNLAENSSYMHVYRELEQAIRGADAQEDLR;KAEGATLSNATGAVESTSQAGDR;ALYDYDGQEQDELSFK;LGEEDEQGWCRGRLDSGQLGLYPANYVEAI | 4.65 | Catalytic activity and binding |
26 | IPI00110265 | Isoform 1 of NAD-dependent deacetylase sirtuin-2 | 255 | 1.80E-21 | 11 | 35 | 43856 | 5.23 | NLFTQTLGLGSQK;LLDELTLEGVTRYMQSER;VICLVGAGISTSAGIPDFR;HPEPFFALAK;CYTQNIDTLER;IFSEATPRCEQCQSVVKPDIVFFGENLPSR;APLATPR;ELEDLVRREHANIDAQSGSQAPNPSTTISPGK | 1.57 | Catalytic activity and binding |
27 | IPI00649438 | Novel protein similar to splicing factor, arginine/serine-rich 3 | 80 | 0.00061 | 3 | 19 | 19404 | 11.41 | NPPGFAFVEFEDPRDAADAVR;NRGLPPSWGR | 1.65 | Metabolic process |
Day 21, down-regulated proteins | |||||||||||
28 | IPI00133522 | Protein disulfide-isomerase | 408 | 9.00E-37 | 17 | 37 | 57507 | 4.79 | SNFEEALAAHK;ALAPEYAKR;LKAEGSEIR;VDATEESDLAQQYGVR;YQLDKDGVVLFKKFDEGRNNFEGEITK;HNQLPLVIEFTEQTAPK;ILFIFIDSDHTDNQR;KEECPAVR;YKPESDELTAEKITEFCHR;IKPHLMSQEVPEDWDKQPVKVLVGANFEEVAFDEKK;LGETYKDHENIIIAK;FFPASADR | −1.52 | Metabolic process |
29 | IPI00756786 | SH3-domain GRB2-like endophilin B2 | 258 | 9.00E-22 | 11 | 26 | 45165 | 5.44 | KLASDAGIFFTR;FGQAEKTELDAHFENLLAR;NWTER;QTEVLLQPNPSAR;ATCEGDTVPDFQETRPR;VAQTEFDRQAEVTRLLLEGISSTHVNHLR;SQTTYYAQCYR | −1.50 | Cellular process |
30 | IPI00111556 | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 239 | 7.20E-20 | 10 | 34 | 36123 | 5.21 | SPDTNYLFMGDYVDR;QITQVYGFYDECLRKYGNANVWK;LQEVPHEGPMCDLLWSDPDDRGGWGISPR;AHQLVMEGYNWCHDRNVVTIFSAPNYCYR;YSFLQFDPAPR | −2.10 | Metabolic process |
31 | IPI00798544 | Isoform 2 of Enolase-phosphatase E1 | 384 | 2.30E-34 | 11 | 24 | 25457 | 4.92 | QLQGHMWK;MKAEFFADVVPAVRRWREAGMKVYIYSSGSVEAQK;GHKVDSESYRK | −3.54 | Metabolic process |
32 | IPI00230145 | Ferritin heavy chain | 408 | 9.00E-37 | 11 | 65 | 21224 | 5.53 | QNYHQDAEAAINR;YFLHQSHEEREHAEK;KPDRDDWESGLNAMECALHLEKSVNQSLLELHKLATDKNDPHLCDFIETYYLSEQVK;ELGDHVTNLRKMGAPEAGMAEYLFDKHTLGHGDES | −1.56 | Immune system process |
Day 21, up-regulated proteins | |||||||||||
33 | IPI00403810 | Tubulin alpha-1C chain | 174 | 2.30E-13 | 5 | 16 | 50562 | 4.96 | AVFVDLEPTVIDEVR;EIIDLVLDR;NLDIERPTYTNLNR;FDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEK | 1.56 | Structural molecule activity |
34 | IPI00221540 | Erlin-2 | 339 | 7.20E-30 | 8 | 17 | 38077 | 5.37 | SVQTTLQTDEVK;VTKPNIPEAIRR;VAQVAEITYGQK;KISEIEDAAFLAR;AKADAECYTALK | 1.85 | Metabolic process |
35 | IPI00230192 | Isoform Alpha-1 of Guanine nucleotide-binding protein G(o) subunit alpha | 170 | 5.70E-13 | 5 | 16 | 40629 | 5.34 | AMDTLGVEYGDKER;LWGDSGIQECFNR;YYLDSLDRIGAGDYQPTEQDILR;LFDVGGQR | 1.54 | Signal transducer activity |
36 | IPI00653664 | Isoform 1 of Enolase-phosphatase E1 | 365 | 1.80E-32 | 11 | 27 | 28696 | 4.79 | EYLQTHWEEEECQQDVSLLR;QLQGHMWK;MKAEFFADVVPAVRRWREAGMKVYIYSSGSVEAQK;VDSESYRK | 1.96 | Metabolic process |
37 | IPI00130280 | ATP synthase subunit alpha | 376 | 1.40E-33 | 11 | 18 | 59830 | 9.22 | TGTAEMSSILEERILGADTSVDLEETGRVLSIGDGIAR;NVQAEEMVEFSSGLK;TGAIVDVPVGEELLGR;APGIIPRISVREPMQTGIKAVDSLVPIGR;ELI IGDR | 2.43 | Transporter activity and developmental process |
38 | IPI00129161 | Somatotropin | 201 | 4.50E-16 | 14 | 45 | 24986 | 5.97 | AQHLHQLAADTYKEFERAYIPEGQR;EEAQQRTDMELLR;IFTNSLMFGTSDR;LKDLEEGIQALMQELEDGSPR;QTYDKFDANMR;AETYLR;RFVESSCAF | 19.73 | Cell proliferation |
Spots 39–46 were down-regulated on both day 14 and day 21 | |||||||||||
39 | IPI00119113 | V-type proton ATPase subunit B | 641 | 4.50E-60 | 34 | 64 | 56857 | 5.57 | MALRAMRGIVNGAAPELPVPTGGPMAGAR;NYLSQPR;YAEIVHLTLPDGTKR;AVVQVFEGTSGIDAKKTSCEFTGDILRTPVSEDMLGR;GPVVLAEDFLDIMGQPINPQCRIYPEEMIQTGISAIDGMNSIAR;IPIFSAAGLPHNEIAAQICR;SKDVVDYSEENFAIVFAAMGVNMETAR;LALTTAEFLAYQCEKHVLVILTDMSSYAEALR;RGFPGYMYTDLATIYER;QIYPPINVLPSLSRLMKSAIGEGMTR;DHADVSNQLYACYAIGK;AVVGEEALTSDDLLYLEFLQK;NFITQGPYENRTVYETLDIGWQLLR;RIPQSTLSEFYPR | −2.11 | Transporter activity |
40 | IPI00759870 | Isoform 4 of Heterogeneous nuclear ribonucleoproteins C1/C2 | 201 | 4.50E-16 | 3 | 9 | 32261 | 4.95 | GFAFVQYVNER;MYSYPARVPPPPPIAR | −1.52 | Metabolic process |
41 | IPI00115117 | Stomatin-like protein 2 | 231 | 4.50E-19 | 12 | 32 | 38475 | 8.95 | NTVILFVPQQEAWVVER;ILEPGLNVLIPVLDR;ASYGVEDPEYAVTQLAQTTMR;YEIKDIHVPPRVKESMQMQVEAER;ATVLESEGTR;APVPGAQNSSQSRRDVQATDTSIEELGR | −2.33 | Organelle and organelle part |
42 | IPI00830393 | Putative uncharacterized protein Cops6 | 209 | 7.20E-17 | 8 | 31 | 33855 | 5.65 | SQEGRPMQVIGALIGK;NIEVMNSFELLSHTVEEK;QVCEIIESPLFLK;IGVDHVAR;LILEYVKASEAGEVPFNHEILR;TCNTMNQFVNKFNVLYDR | −2.91 | Cellular process and metabolic process |
43 | IPI00311515 | Beta-soluble NSF attachment protein | 415 | 1.80E-37 | 20 | 69 | 33878 | 5.32 | EAVQLMAEAEKR;ASHSFLRGLFGGNTRIEEACEMYTR;NWSAAGNAFCQAAK;HDSATSFVDAGNAYK;HHITIAEIYETELVDIEKAIAHYEQSADYYKGEESNSSANK;VAAYAAQLEQYQKAIEIYEQVGANTMDNPLLK;AALCHFIVDELNAKLALEKYEEMFPAFTDSRLLEAHEEQNSEAYTEAVKEFDSISRLDQWLTTMLLR; | −1.67 | Cellular process |
44 | IPI00322312 | Rho GDP-dissociation inhibitor 1 | 396 | 1.40E-35 | 9 | 42 | 23450 | 5.12 | SIQEIQELDKDDESLR;YKEALLGRVAVSADPNVPNVIVTR;EGVEYR;YIQHTYR;IDKTDYMVGSYGPR;FTDDDKTDHLSWEWNLTIK | −1000000 | Enzyme regulator activity |
45 | IPI00133853 | UPF0687 protein C20orf27 homolog | 268 | 9.00E-23 | 8 | 50 | 19692 | 6.19 | FAAGHDAEGSQSHVHFDEK;YEITFTLPPVR;ETPVHSLHLKLLSVTPTSEGYSIK;EGVLKEEMLLACEGDIGTCVR;HHGTPMLLDGVK | −1.70 | Cell part and organelle part |
46 | IPI00315504 | ADP-ribosylation factor-like protein 2 | 75 | 0.0016 | 2 | 8 | 21022 | 5.67 | ELQSLLVEER;SHHWR | −1.66 | Binding |
Spots 47–56 were up-regulated on both day 14 and day 21 | |||||||||||
47 | IPI00129526 | Endoplasmin | 766 | 1.40E-72 | 33 | 38 | 92703 | 4.74 | TDDEVVQREEEAIQLDGLNASQIR;FAFQAEVNR;NKEIFLRELISNASDALDKIRLISLTDENALAGNEELTVK;NLLHVTDTGVGMTREELVKEVEEDEYKAFYK;ESDDPMAYIHFTAEGEVTFKSILFVPTSAPRGLFDEYGSKK;RVFITDDFHDMMPKYLNFVKGVVDSDDLPLNVSR;IADEKYNDTFWK;LGVIEDHSNR;FQSSHHSTDITSLDQYVER;QDKIYFMAGSSRKEAESSPFVEREATEKEFEPLLNWMK;LTESPCALVASQYGWSGNMER;DISTNYYASQKKTFEINPR;AYGDRIER | 1.54 | Metabolic process |
48 | IPI00123639 | Calreticulin | 292 | 3.60E-25 | 5 | 16 | 48136 | 4.33 | EQFLDGDAWTNR;HEQNIDCGGGYVK;IDNSQVESGSLEDDWDFLPPKKIKDPDAAKPEDWDER;GEWKPR | 1.66 | Immune system process, |
49 | IPI00131830 | Serine protease inhibitor A3K | 175 | 1.80E-13 | 6 | 21 | 47021 | 5.05 | ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;AVLDVAETGTEAAAATGVIGGIR; | 1000000 | Enzyme regulator activity |
50 | IPI00131830 | Serine protease inhibitor A3K | 336 | 1.40E-29 | 9 | 27 | 47021 | 5.05 | GKTMEEILEGLK;DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;AVLDVAETGTEAAAATGVIGGIR | 12.57 | Enzyme regulator activity |
51 | IPI00131830 | Serine protease inhibitor A3K | 316 | 1.40E-27 | 8 | 26 | 47021 | 5.05 | DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR | 5.29 | Enzyme regulator activity |
52 | IPI00131830 | Serine protease inhibitor A3K | 187 | 1.10E-14 | 5 | 16 | 47021 | 5.05 | ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLR;AVLDVAETGTEAAAATGVIGGIR | 1000000 | Enzyme regulator activity |
53 | IPI00131287 | Isoform 1 of N-terminal EF-hand calcium-binding protein 2 | 374 | 2.30E-33 | 11 | 28 | 43870 | 5.18 | APLVPDIPSADPGPGPAASRGGTAVILDIFR;KVYEGGSNVDQFVTR;YGGPTPPYIPNHK;TLSFDLQQRLSDEEGTNMHLQLVRQEMAVCPEQLSEFLDSLR;NCFHVAAVR | 1000000 | Cell part and binding |
54 | IPI00928020 | Putative uncharacterized protein Otub1 | 331 | 4.50E-29 | 7 | 25 | 28190 | 5.15 | IQQEIAVQNPLVSER;EYAEDDNIYQQK;YSYIRKTRPDGNCFYR;LLTSGYLQR;FFEHFIEGGR | 1.89 | Metabolic process |
55 | IPI00323571 | Apolipoprotein E | 329 | 7.20E-29 | 14 | 39 | 35901 | 5.56 | FWDYLR;ELEEQLGPVAEETR;LGADMEDLR;NEVHTMLGQSTEEIR;LSTHLR;LGPLVEQGR;TANLGAGAAQPLR;AQAFGDR;GRLEEVGNQAR;SKMEEQTQQIRLQAEIFQAR;GWFEPIVEDMHR | 1000000 | Binding and antioxidant activity, |
56 | IPI00278230 | NFU1 iron-sulfur cluster scaffold homolog | 131 | 4.50E-09 | 5 | 17 | 28922 | 4.92 | FIPGKPVLETRTMDFPTPAAAFR;IRPTVQEDGGDVIYRGFEDGIVR | 1000000 | Organelle and organelle part |